関連する実験動画
Updated: Jan 8, 2026
01:27
Pulmonary Embolism III: Nursing Management
Published on: June 19, 2025
320
抗生物質 耐性
1Department of Biology, Technion - Israel Institute of Technology, Haifa 3200003, Israel.
Cell
|February 24, 2018
まとめ
バクテリアの薬剤耐性には 抗生物質に対する複数の防御線が含まれています 遺伝子の変異から 遺伝子の輸入に至るまで ゲノムの変化は これらの多様な抵抗メカニズムをコードし 複雑な関係を示しています
科学分野:
- 微生物学
- 遺伝学
- 分子生物学
背景:
- 薬剤耐性菌は 世界的に大きな健康上の脅威です
- 新しい治療法の開発には 耐性メカニズムを理解することが重要です
- 細菌は 抗生物質の作用を回避するために 様々な戦略を採用しています
研究 の 目的:
- バクテリアの薬剤耐性における 連続的な防御線を解明するためです
- これらのレジスタンスメカニズムのゲノム基盤を特徴づける.
- 耐性メカニズムと遺伝的変化の関係を調べる
主な方法:
- 抗生物質に対する細菌の防御機構の分析
- 薬剤耐性に関連したゲノム変異の調査
- 遺伝要素の組み立てと水平遺伝子の移転の検査
主要な成果:
- バクテリアの耐性には,薬物の侵入,蓄積,標的結合,および毒性を標的とした連続的な防御が含まれます.
- ポイント変異,遺伝要素の組み立て,水平の遺伝子インポートを含むゲノムの変化は,耐性をコードします.
- 耐性メカニズムと 遺伝的変化をコードするメカニズムの間には 複雑な多対多の関係がある.
結論:
- バクテリアの薬剤耐性は 多様な防御戦略を含む多面的なプロセスです
- ゲノムの可塑性は 細菌に幅広い抵抗機構を提供します
- これらの多様なメカニズムとその遺伝的基盤をターゲットにすることが 細菌感染と闘うための鍵です
関連する概念動画
Pulmonary Embolism III: Nursing Management
320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Pulmonary Embolism I: Introduction
464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pneumothorax-II
852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
852
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K